INPLASY202450040

Insights into the Safety Profile of Upadacitinib in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Keywords: Upadacitinib, inflammatory bowel diseases, ulcerative colitis, Crohn's disease, safety, adverse events, Janus kinase inhibitors.

Download PDF - 202450040

Review Status: Ongoing